サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566981

ビンポセチン市場：製品タイプ別、流通チャネル別：世界の機会分析と産業予測、2024～2033年

Vinpocetine Market By Product Type (Tablet, Injection) , By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
ビンポセチン市場：製品タイプ別、流通チャネル別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ビンポセチン市場

ビンポセチン市場は2023年に2億米ドルと評価され、2024～2033年までCAGR 3.5%で成長し、2033年には3億米ドルに達すると予測されています。

Vinpocetineは、Vinca minorという植物に由来する天然化合物に類似した合成化学品です。この化合物は、頭部外傷、脳卒中、パーキンソン病中の認知症、加齢に伴う記憶喪失、アルツハイマー病など、さまざまな症状や疾患の治療に使用されるマルチ作用薬です。ビンポセチンの主要作用機序は、脳血流の促進であり、その結果、脳への栄養と酸素の供給が改善されます。その顕著な安全性プロファイルのために、この化学品は、認知力と記憶力を強化するための栄養補助食品の形で利用できるようになりました。

特に高齢者人口の急激な増加による認知障害の有病率の増加が、ビンポセチン市場の成長を大きく後押ししています。加えて、神経変性疾患の適時予防に関する意識の高まりに伴い、予防措置として栄養補助食品の摂取を始める人が増えており、ビンポセチンの需要を押し上げています。栄養補助食品の広がりは、市場の成長を顕著に増大させる。現在、ビンポセチンの認知サポート以外の用途に関する調査が動向しています。この化学品は、アテローム性動脈硬化症や肺線維症における肺胞上皮細胞の損傷など、多様な症状の治療のために試験されています。このような用途の拡大は、市場開拓のための新たなセグメントを提示すると予測されます。

しかし、この化学品は、その分類と効能のために、いくつかの国でさまざまな規制上のハードルに直面しており、これが市場の広範な成長を抑制しています。さらに、アルツハイマー病や認知症の治療には、代替となる有能な薬剤がいくつかあり、市場開拓の妨げとなっています。例えば、米国食品医薬品局は最近、抗アミロイドモノクローナル抗体である新薬レカネマブの認知症治療への有効性を承認しました。この薬は、認知症の特徴であるアミロイドβ斑に結合することで、特に認知症の素因を対象にしています。様々な研究がレカネマブの有効性を提唱しており、ビンポセチン市場拡大の課題となっています。

セグメント別レビュー

ビンポセチン市場は、製品タイプ、流通チャンネル、地域に区分されます。製品タイプ別では、市場は錠剤と注射剤に二分されます。流通チャンネル別では、小売薬局、病院薬局、オンライン薬局に分けられます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

製品タイプ別では、2023年に錠剤セグメントが市場で高いシェアを獲得。

流通チャンネル別では、小売薬局セグメントが2023年に高い市場シェアを占めました。

地域別では、北米がビンポセチン市場で支配的な地位を占めています。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 新製品開発/主要企業の製品マトリックス
  • 規制ガイドライン
  • クライアントの関心に応じた追加企業プロファイル
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 ビンポセチン市場：製品タイプ別

  • 市場概要
  • 錠剤
  • 注射剤

第5章 ビンポセチン市場：流通チャンネル別

  • 市場概要
  • 小売薬局
  • 病院薬局
  • オンライン薬局

第6章 ビンポセチン市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国のビンポセチン市場
    • カナダのビンポセチン市場
    • メキシコのビンポセチン市場
  • 欧州
    • 主要市場動向と機会
    • ドイツのビンポセチン市場
    • フランスのビンポセチン市場
    • 英国のビンポセチン市場
    • イタリアのビンポセチン市場
    • スペインのビンポセチン市場
    • その他の欧州のビンポセチン市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本のビンポセチン市場
    • 中国のビンポセチン市場
    • オーストラリアのビンポセチン市場
    • インドのビンポセチン市場
    • 韓国のビンポセチン市場
    • その他のアジア太平洋のビンポセチン市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのビンポセチン市場
    • サウジアラビアのビンポセチン市場
    • 南アフリカ共和国のビンポセチン市場
    • その他のラテンアメリカ・中東・アフリカのビンポセチン市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • Northeast Pharmaceutical Group Co., Ltd.
  • COVEX
  • Runhong
  • Liaoning Zhiying
  • Sun Pharmaceuticals Industries Ltd
  • Welman
  • Micro Labs Ltd
  • Gedeon Richter Plc.
目次
Product Code: A324539

Vinpocetine Market

The vinpocetine market was valued at $0.2 billion in 2023 and is projected to reach $0.3 billion by 2033, growing at a CAGR of 3.5% from 2024 to 2033.

Vinpocetine is a synthetic chemical that holds resemblance with a natural compound derived from the plant Vinca minor. The compound is a multi-action agent used to treat various conditions and diseases, including head injuries, stroke, dementia during Parkinson's disease, age-related memory loss, and Alzheimer's disease. The primary action mechanism of vinpocetine involves the enhancement of cerebral blood flow, resulting in improved nutrient and oxygen delivery to the brain. Owing to its remarkable safety profile, the chemical has been made available in the form of dietary supplement for enhanced cognition and memory.

Increase in the prevalence of cognitive disorders, particularly due to exponential growth in the elderly population has significantly driven the growth of the vinpocetine market. In addition, with rising awareness regarding the timely prevention of neurodegenerative diseases, individuals are beginning the consumption of dietary supplements as a precautionary measure, thereby boosting the demand for vinpocetine. The expanding landscape of dietary supplements augments the growth of the market notably. Currently, explorations regarding the applications of vinpocetine beyond its cognitive support are trending. The chemical has been tested for the treatment of diverse conditions such as atherosclerosis and injured alveolar epithelial cells in pulmonary fibrosis. Such expansion of applications is projected to present new segments for market development.

However, the chemical faces different regulatory hurdles in several countries owing to its classification and efficacy, which restrains the widespread growth of the market. Furthermore, several alternative and competent alternatives are available for the treatment of Alzheimer's and dementia, hampering market development. For instance, the U.S. Food and Drug Administration and recently approved the efficacy of a novel drug-lecanemab-an anti-amyloid monoclonal antibody, for the treatment of dementia. The drug particularly targets the elementary causes of the disease by binding to amyloid-beta plaques, the hallmark of the disease. Different studies have advocated for the effectiveness of lecanemab, presenting challenges for the expansion of the vinpocetine market.

Segment Review

The vinpocetine market is segmented into product type, distribution channel, and region. On the basis of product type, the market is bifurcated into tablet and injection. As per distribution channel, it is divided into retail pharmacies, hospital pharmacies, and online pharmacies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the tablet segment acquired a high stake in the market in 2023.

As per distribution channel, the retail pharmacies segment accounted for a high market share in 2023.

Region wise, North America holds a dominant position in the vinpocetine market.

Competition Analysis

The leading players operating in the global vinpocetine market include Northeast Pharmaceutical Group Co., Ltd., Gedeon Richter, COVEX, Runhong, Liaoning Zhiying, Sun Pharmaceuticals Industries Ltd, Welman, and Micro Labs Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

  • Tablet
  • Injection

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Northeast Pharmaceutical Group Co., Ltd.
    • COVEX
    • Runhong
    • Liaoning Zhiying
    • Sun Pharmaceuticals Industries Ltd
    • Welman
    • Micro Labs Ltd
    • Gedeon Richter Plc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VINPOCETINE MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Tablet
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Injection
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: VINPOCETINE MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Distribution Channel
  • 5.2. Retail Pharmacies
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Hospital Pharmacies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Online Pharmacies
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: VINPOCETINE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Product Type
    • 6.2.3. Market Size and Forecast, By Distribution Channel
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Vinpocetine Market
      • 6.2.5.1. Market Size and Forecast, By Product Type
      • 6.2.5.2. Market Size and Forecast, By Distribution Channel
    • 6.2.6. Canada Vinpocetine Market
      • 6.2.6.1. Market Size and Forecast, By Product Type
      • 6.2.6.2. Market Size and Forecast, By Distribution Channel
    • 6.2.7. Mexico Vinpocetine Market
      • 6.2.7.1. Market Size and Forecast, By Product Type
      • 6.2.7.2. Market Size and Forecast, By Distribution Channel
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Product Type
    • 6.3.3. Market Size and Forecast, By Distribution Channel
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Vinpocetine Market
      • 6.3.5.1. Market Size and Forecast, By Product Type
      • 6.3.5.2. Market Size and Forecast, By Distribution Channel
    • 6.3.6. France Vinpocetine Market
      • 6.3.6.1. Market Size and Forecast, By Product Type
      • 6.3.6.2. Market Size and Forecast, By Distribution Channel
    • 6.3.7. UK Vinpocetine Market
      • 6.3.7.1. Market Size and Forecast, By Product Type
      • 6.3.7.2. Market Size and Forecast, By Distribution Channel
    • 6.3.8. Italy Vinpocetine Market
      • 6.3.8.1. Market Size and Forecast, By Product Type
      • 6.3.8.2. Market Size and Forecast, By Distribution Channel
    • 6.3.9. Spain Vinpocetine Market
      • 6.3.9.1. Market Size and Forecast, By Product Type
      • 6.3.9.2. Market Size and Forecast, By Distribution Channel
    • 6.3.10. Rest of Europe Vinpocetine Market
      • 6.3.10.1. Market Size and Forecast, By Product Type
      • 6.3.10.2. Market Size and Forecast, By Distribution Channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Product Type
    • 6.4.3. Market Size and Forecast, By Distribution Channel
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Vinpocetine Market
      • 6.4.5.1. Market Size and Forecast, By Product Type
      • 6.4.5.2. Market Size and Forecast, By Distribution Channel
    • 6.4.6. China Vinpocetine Market
      • 6.4.6.1. Market Size and Forecast, By Product Type
      • 6.4.6.2. Market Size and Forecast, By Distribution Channel
    • 6.4.7. Australia Vinpocetine Market
      • 6.4.7.1. Market Size and Forecast, By Product Type
      • 6.4.7.2. Market Size and Forecast, By Distribution Channel
    • 6.4.8. India Vinpocetine Market
      • 6.4.8.1. Market Size and Forecast, By Product Type
      • 6.4.8.2. Market Size and Forecast, By Distribution Channel
    • 6.4.9. South Korea Vinpocetine Market
      • 6.4.9.1. Market Size and Forecast, By Product Type
      • 6.4.9.2. Market Size and Forecast, By Distribution Channel
    • 6.4.10. Rest of Asia-Pacific Vinpocetine Market
      • 6.4.10.1. Market Size and Forecast, By Product Type
      • 6.4.10.2. Market Size and Forecast, By Distribution Channel
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Product Type
    • 6.5.3. Market Size and Forecast, By Distribution Channel
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Vinpocetine Market
      • 6.5.5.1. Market Size and Forecast, By Product Type
      • 6.5.5.2. Market Size and Forecast, By Distribution Channel
    • 6.5.6. Saudi Arabia Vinpocetine Market
      • 6.5.6.1. Market Size and Forecast, By Product Type
      • 6.5.6.2. Market Size and Forecast, By Distribution Channel
    • 6.5.7. South Africa Vinpocetine Market
      • 6.5.7.1. Market Size and Forecast, By Product Type
      • 6.5.7.2. Market Size and Forecast, By Distribution Channel
    • 6.5.8. Rest of LAMEA Vinpocetine Market
      • 6.5.8.1. Market Size and Forecast, By Product Type
      • 6.5.8.2. Market Size and Forecast, By Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Northeast Pharmaceutical Group Co., Ltd.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. COVEX
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Runhong
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Liaoning Zhiying
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Sun Pharmaceuticals Industries Ltd
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Welman
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Micro Labs Ltd
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Gedeon Richter Plc.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments